戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1658823作成日:2026年10月26日

1H-Indazole → Hydrochloric Acid

https://huagongshe.com/reaction/1658823

反応式

関与物質

役割名称HCID仕込み量
反応物1H-IndazoleHCID 9221—
反応物BenzydamineHCID 12555—
反応物Benzydamine HydrochlorideHCID 65464—
反応物3-Chloro-N,N-dimethyl-1-propanamineHCID 66960—
反応物SodiumHCID 5360545—
反応物HCID 178518894HCID 178518894—
溶媒O-XyleneHCID 7237—
生成物Hydrochloric AcidHCID 313—
生成物BenzydamineHCID 12555—

反応手順

As described in the aforementioned United States patent specification, indazole compounds embraced by the foregoing general formula II are biologically active in that some manifest analgesic, antiinflammatory and myorelaxing activity. Probably the best known of such compounds at the present time is 1-benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole, commonly referred to as benzydamine, which in the form of the hydrochloride salt, is employed in chemotherapy as an analgesic, antipyretic and/or antiinflammatory agent. In this role, the benzydamine hydrochloride is asssociated in pharmaceutical compositions with pharmaceutically acceptable organic or inorganic, solid or liquid carriers. According to the process described in the aforementioned United States specification, this compound is prepared by heating the sodium salt of 1-benzyl-3-hydroxy-1H-indazole with 3-chloropropyldimethylamine in xylene as an inert solvent. Treatment of the 1benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole so-obtained with ethereal hydrochloric acid yields the corresponding hydrochloride salt, with a melting point of 160°C.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US03966761
出典データセットuspto-grants-1976_06
ORD IDord-50f874291df4493cb6cbb0d2eb9897fd
出典メモuspto-grants-1976_06